PT1452171E - Suspensões líquidas farmacêuticas - Google Patents

Suspensões líquidas farmacêuticas Download PDF

Info

Publication number
PT1452171E
PT1452171E PT04013422T PT04013422T PT1452171E PT 1452171 E PT1452171 E PT 1452171E PT 04013422 T PT04013422 T PT 04013422T PT 04013422 T PT04013422 T PT 04013422T PT 1452171 E PT1452171 E PT 1452171E
Authority
PT
Portugal
Prior art keywords
particles
quot
stable
pfc
liquid
Prior art date
Application number
PT04013422T
Other languages
English (en)
Portuguese (pt)
Inventor
Bruce Joseph Roser
Arcadio Garcia De Castro
Original Assignee
Nova Bio Pharma Technologies L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nova Bio Pharma Technologies L filed Critical Nova Bio Pharma Technologies L
Publication of PT1452171E publication Critical patent/PT1452171E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT04013422T 2000-10-13 2000-10-13 Suspensões líquidas farmacêuticas PT1452171E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Publications (1)

Publication Number Publication Date
PT1452171E true PT1452171E (pt) 2010-03-08

Family

ID=21741883

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04013422T PT1452171E (pt) 2000-10-13 2000-10-13 Suspensões líquidas farmacêuticas

Country Status (12)

Country Link
EP (1) EP1328255A1 (xx)
JP (1) JP2004513093A (xx)
KR (1) KR20030096224A (xx)
CN (1) CN100339066C (xx)
AU (2) AU1198601A (xx)
CA (2) CA2424656C (xx)
ES (1) ES2337252T3 (xx)
MX (1) MXPA03003236A (xx)
NO (1) NO20031706D0 (xx)
PL (1) PL360052A1 (xx)
PT (1) PT1452171E (xx)
WO (1) WO2002032402A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502825A1 (en) * 2002-10-22 2004-05-06 Dainippon Pharmaceutical Co., Ltd. Stabilized composition
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
CA2562606A1 (en) 2004-04-13 2005-10-27 Cambridge Biostability Limited Liquids containing suspended glass particles
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
WO2009091017A1 (ja) * 2008-01-18 2009-07-23 Asahi Kasei Pharma Corporation 安定な医薬組成物
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (en) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension of particles with drug
WO2011007327A2 (en) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension for therapeutic use and device for delivering said suspension
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
TWI654098B (zh) 2014-03-24 2019-03-21 日商精工愛普生股份有限公司 Belt printing device and tape printing system
RU2016141948A (ru) * 2014-03-27 2018-04-27 Новартис Аг Высушенные распылением дисперсии твердое-в-масле-в-воде активных фармацевтических ингредиентов для ингаляции

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (xx) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Also Published As

Publication number Publication date
CA2424656C (en) 2010-03-23
KR20030096224A (ko) 2003-12-24
CA2689856A1 (en) 2002-04-25
AU1198601A (en) 2002-04-29
PL360052A1 (en) 2004-09-06
CN100339066C (zh) 2007-09-26
NO20031706L (no) 2003-04-11
CA2689856C (en) 2013-09-24
CN1527699A (zh) 2004-09-08
AU2001211986B2 (en) 2007-04-26
NO20031706D0 (no) 2003-04-11
CA2424656A1 (en) 2002-04-25
EP1328255A1 (en) 2003-07-23
WO2002032402A1 (en) 2002-04-25
ES2337252T3 (es) 2010-04-22
MXPA03003236A (es) 2004-12-03
JP2004513093A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
US6190701B1 (en) Composition and method for stable injectable liquids
PT1452171E (pt) Suspensões líquidas farmacêuticas
Parumasivam et al. Dry powder inhalable formulations for anti-tubercular therapy
ES2219704T3 (es) Nanoparticulas estabilizadas y filtrables en condiciones esteriles.
AU656919B2 (en) Drug delivery vehicles suspended in nonaqueous perfluorinated carrier
EP1750668B1 (en) Liquids containing suspended glass particles
AU2001211986A1 (en) Composition and method for stable injectable liquids
US20110045079A1 (en) Dry powders of cellular material
CN101252916B (zh) 生物材料稳定性的改进
JP2002504090A (ja) 液体調合物における安定な粒子
US20020094318A1 (en) Aerogel powder therapeutic agents
US20010055610A1 (en) Medicament administration system
AU2005203369B2 (en) Pharmaceutical liquid suspensions
JP4027881B2 (ja) 安定注射液用の組成物および方法
JP4382706B2 (ja) 医薬液体懸濁物
EP1452171B1 (en) Pharmaceutical liquid suspensions
RU2259817C2 (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
KR950005867B1 (ko) 흡입제
KR100743442B1 (ko) 약제적 액체 현탁액
NZ525026A (en) A two-component composition comprising particles of sugar glass and a biocompatible liquid perfluorocarbon
CN100594937C (zh) 稳定的注射液组合物和方法
NZ538681A (en) A pharmaceutical composition comprising active biological ingredient carried by particles that form a stable suspension in a liquid indefinitely
WO2015001160A1 (es) Nanopartícula lipídica de polimixina
ES2599629T3 (es) Una emulsión que contiene una sustancia medicinal no viva
RU2003113537A (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки